Agenda
WEDNESDAY, April 10, 2024
4:00 pm – 6:00 pm: Early Registration
Note that there's a door prize drawing for Wednesday registrants.
or, THURSDAY, April 11, 2024
7:00 am – 7:50 am: On-site Registration
Quick Schedule
THURSDAY, April 11, 2024
7:15 am – 7:50 am: Breakfast
7:50 am – 1:00 pm: Educational Sessions
FRIDAY, April 12, 2024
7:15 am – 7:40 am: Breakfast
7:40 am – 12:15 pm: Educational Sessions
12:30 pm – 2:30 pm: Lunch/Educational Sessions
SATURDAY, April 13, 2024
7:15 am – 7:40 am: Breakfast
7:40 am – 12:15 pm: Educational Sessions
The conference adjourns on Saturday, April 13, 2024 at 12:15 pm.
Educational Sessions
The agenda for the 2024 conference will be posted shortly. In the meantime, we are happy to provide you with last year's agenda to give you a sense of our conference. Topics and speakers will vary from 2023.
MONDAY, May 1, 2023 Day 1: Diabetes and Cardio-Renal Disease Disease Management with Cases |
||
7:50 am – 8:00 am | Welcome | J. Basile, MD |
8:00 am – 9:00 am | Contrasting the GLP-1 and Dual Incretin Receptor Agonists with SGLT2 Inhibitors in the Early Treatment of Diabetes | M. McDonnell, MD |
9:00 am – 9:45 am | Novel Therapies in Resistant Hypertension | G. Bakris, MD |
9:45 am | BREAK | |
10:00 am – 10:45 am | Selecting Therapies in the Older Outpatient with Diabetes: A Cardiometabolic Approach | M. McDonnell, MD |
10:45 am – 11:45 am | A “Novel“ Pillars Approach to Slowing Diabetic Kidney Disease Progression | G. Bakris, MD |
11:45 am – 1:00 pm | Cases in Diabetes, Kidney, and Cardio-Renal Disease | M. McDonnell, MD & G. Bakris, MD |
TUESDAY, May 2, 2023 Day 2: Comprehensive Obesity Management and NAFLD/NASH with Case Studies |
||
7:45 am – 8:00 am | Day One Review | Previous Day’s Faculty |
8:00 am – 8:45 am | Basics of Obesity Biology and Weight Loss Physiology | D. Ryan, MD |
8:45 am – 9:30 am | Patient Assessment and Engagement | R. Kushner, MD |
9:30 am | BREAK | |
9:45 am – 10:30 am | Prescribing for Weight Management | R. Kushner, MD |
10:30 am – 11:15 am | Future Lifestyle and Pharmacologic Directions in the Care of the Overweight Patient | D. Ryan, MD |
11:15 am – 12:15 pm | Cases in Obesity Management | R. Kushner, MD & D. Ryan, MD |
12:15 pm | BREAK (Lunch Provided) | |
12:30 pm – 1:30 pm | Clinical Practice Update: Diagnosis and Management of NAFLD | L. VanWagner, MD |
1:30 pm – 2:15 pm | Cases in NAFLD/NASH | L. VanWagner, MD |
WEDNESDAY, May 3, 2023 Day 3: Hypertension and Dyslipidemia Management with Case Studies |
||
7:45 am – 8:00 am | Day Two Review | Previous Day’s Faculty |
8:00 am – 9:00 am | Questions on Evaluating and Treating Hypertension in the Outpatient | J. Basile, MD |
9:00 am – 10:00 am | Recommendations for Optimal LDL Treatment to Prevent ASCVD: Who to Treat and What Therapies to Use | P. Jones, MD |
10:00 am | BREAK | |
10:15 am – 11:00 am | What the Clinician Needs to Know About Triglycerides and HDL Cholesterol | P. Jones, MD |
11:00 am – 12:15 pm | Cases on Dyslipidemia and Hypertension | J. Basile, MD & P. Jones, MD |